Trials / Sponsors / ABLi Therapeutics, Inc.
ABLi Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A PK Study of IkT-148009 in Older and Elderly Healthy Subjects Healthy | Phase 1 | 2023-06-21 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease Parkinson Disease | Phase 2 | 2023-05-15 |
| Completed | A Phase I Dosing Study of IkT-148009. Healthy | Phase 1 | 2023-02-21 |
| Completed | A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Pati Healthy Elderly, Parkinson Disease | Phase 1 | 2021-02-16 |